Table of Contents
ISRN Endoscopy
Volume 2013 (2013), Article ID 408931, 5 pages
http://dx.doi.org/10.5402/2013/408931
Clinical Study

Influence of Helicobacter pylori Infection on the Small Intestinal Mucosa

Department of Gastroenterology, Dokkyo Medical University, Tochigi, Mibu 321-0293, Japan

Received 4 June 2013; Accepted 19 August 2013

Academic Editors: B. Braden, P. Figueiredo, and C. Romano

Copyright © 2013 Mitsunori Maeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Godlewska, A. Dzwonek, M. Mikuła et al., “Helicobacter pylori protein oxidation influences the colonization process,” International Journal of Medical Microbiology, vol. 296, no. 4-5, pp. 321–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Hirasawa, M. Tatsuta, H. Iishi et al., “Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori,” American Journal of Gastroenterology, vol. 94, no. 9, pp. 2398–2402, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Honda, T. Fujioka, M. Tokieda, T. Gotoh, A. Nishizono, and M. Nasu, “Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils,” Scandinavian Journal of Gastroenterology, vol. 33, no. 5, pp. 454–460, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Veenendaal, J. M. Gotz, V. Schroijen et al., “Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies,” Journal of Clinical Pathology, vol. 48, no. 11, pp. 990–993, 1995. View at Google Scholar · View at Scopus
  5. C. Granberg, A. Mansikka, O. P. Lehtonen et al., “Diagnosis of Helicobacter pylori infection by using Pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies,” Journal of Clinical Microbiology, vol. 31, no. 6, pp. 1450–1453, 1993. View at Google Scholar · View at Scopus
  6. J. L. Wallace, S. Syer, E. Denou et al., “Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis,” Gastroenterology, vol. 141, no. 4, pp. 1314–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Gschwantler, B. Dragosics, H. Wurzer, G. Brandstätter, and W. Weiss, “Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycin,” European Journal of Gastroenterology and Hepatology, vol. 10, no. 7, pp. 579–582, 1998. View at Google Scholar · View at Scopus
  8. F. Mirshahi, G. Fowler, A. Patel, and G. Shaw, “Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity,” Journal of Clinical Pathology, vol. 51, no. 3, pp. 220–224, 1998. View at Google Scholar · View at Scopus
  9. I. M. Nakshabendi, Q. B. Zhang, M. Mokhashi, C. G. Gemmell, F. D. Lee, and R. I. Russell, “Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer,” Helicobacter, vol. 1, no. 3, pp. 155–158, 1996. View at Google Scholar · View at Scopus
  10. P. Malfertheiner and U. Peitz, “The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia,” Gut, vol. 54, supplement 1, pp. i13–i20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Wilcox, “Relationship between nonsteroidal anti-inflammatory drug use, Helicobacter pylori, and gastroduodenal mucosal injury,” Gastroenterology, vol. 113, supplement 6, pp. S85–S92, 1997. View at Google Scholar · View at Scopus
  12. Y. Fukuda, H. Bamba, M. Okui et al., “Helicobacter pylori infection increases mucosal permeability of the stomach and intestine,” Digestion, vol. 63, supplement 1, pp. 93–96, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Campanati, R. Gesuita, M. Giannoni et al., “Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis,” Acta Dermato-Venereologica, vol. 93, no. 2, pp. 161–164, 2013. View at Publisher · View at Google Scholar
  14. E. Savarino, L. Assandri, E. G. Giannini, and V. Savarino, “Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease,” American Journal of Gastroenterology, vol. 106, no. 6, pp. 1171–1172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Petrone, G. Sarkisyan, M. Fernández et al., “Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery,” Archives of Surgery, vol. 146, no. 4, pp. 444–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Dobbs, A. Charlett, S. M. Dobbs et al., “Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study,” Gut Pathogens, vol. 4, no. 1, article 12, 2012. View at Publisher · View at Google Scholar
  17. A. Püspök, C. Dejaco, G. Oberhuber et al., “Influence of Helicobacter pylori infection on the phenotype of Crohn's disease,” American Journal of Gastroenterology, vol. 94, no. 11, pp. 3239–3244, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Higuchi, E. Umegaki, T. Watanabe et al., “Present status and strategy of NSAIDs-induced small bowel injury,” Journal of Gastroenterology, vol. 44, no. 9, pp. 879–888, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Smecuol, M. I. Pinto Sanchez, A. Suarez et al., “Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment,” Clinical Gastroenterology and Hepatology, vol. 7, no. 5, pp. 524–529, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Frieri, G. De Petris, A. Aggio et al., “Gastric and duodenal juxtamucosal pH and Helicobacter pylori,” Digestion, vol. 56, no. 2, pp. 107–110, 1995. View at Google Scholar · View at Scopus
  21. A. Hamlet and L. Olbe, “The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans,” Gastroenterology, vol. 111, no. 2, pp. 391–400, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Meyer-Rosberg, D. R. Scott, D. Rex, K. Melchers, and G. Sachs, “The effect of environmental pH on the proton motive force of Helicobacter pylori,” Gastroenterology, vol. 111, no. 4, pp. 886–900, 1996. View at Google Scholar · View at Scopus
  23. P. Bauerfeind, R. Garner, B. E. Dunn, and H. L. T. Mobley, “Synthesis and activity of Helicobacter pylori urease and catalase at low pH,” Gut, vol. 40, no. 1, pp. 25–30, 1997. View at Google Scholar · View at Scopus
  24. J. A. Castro-Rodriguez, R. Leon-Barua, and M. Penny, “Helicobacter pylori is not a determinant factor of persistent diarrhoea or malnutrition in Peruvian children,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 5, pp. 537–539, 1999. View at Google Scholar
  25. S. Puiac, A. Negrea, A. Richter-Dahlfors, L. Plant, and M. Rhen, “Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 6, pp. 2402–2409, 2009. View at Publisher · View at Google Scholar · View at Scopus